Nvigen is a nanobiotechnology company revolutionizing the field of multifunctional nanoparticles for biomedical applications. Our proprietary nanoparticle-imaging-delivery (NID™) platform enables the engineering of nanoparticles with optimal size, shape, surface, magnetic and optical properties that can be used in sequencing, biopsy, genomics, diagnostics, gene/cell therapy, and drug delivery. We seek to integrate the versatility of nanoscience and innovation to develop solutions that can empower biomedical research.
There is no investment information
No recent news or press coverage available for NVIGEN Inc..